Standard BioTools Regains Nasdaq Compliance, Eliminating Delisting Risk
Reported by Wiseek News
Sentiment
Positive
Importance
7
Price
$1.15
Mkt Cap
$448.923M
52W Low
$0.87
52W High
$1.72
Market data snapshot near publication time
Summary
Standard BioTools has successfully regained compliance with Nasdaq's minimum bid price rule, resolving the deficiency notice it received on April 20, 2026. This positive development, also reported in an 8-K filing today, removes a significant delisting risk that had been an overhang for the company. Regaining compliance enhances investor confidence and ensures the stock's continued listing on a major exchange.
At the time of this announcement, LAB was trading at $1.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $448.9M. The 52-week trading range was $0.87 to $1.72. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.